ScienceTop StoryTop StoryLatest News
A Little-Known Protein Could Be a Major Culprit in Type 2 Diabetes
Sentiment: NeutralHigh Priority
What Happened?
Researchers have identified Miro1, a protein linked to insulin resistance in Type 2 diabetes. Higher levels of Miro1 were found in the muscles of affected individuals, suggesting a new treatment target.
Key points
- Miro1 was found at higher levels in the skeletal muscles of people with Type 2 diabetes.
- Removing Miro1 restored insulin response in preclinical models.
- Exercise reduced Miro1 levels and improved insulin sensitivity in participants.
- The study was published in Nature Communications.
- Dr. John P. Kirwan led the research and is now at the OU Health Harold Hamm Diabetes Center.
Key insights
- Targeting Miro1 may enhance the effectiveness of diabetes treatments.
- Exercise's impact on Miro1 suggests lifestyle changes could be crucial in managing diabetes.
- Further research is needed to confirm the safety and efficacy of targeting Miro1 in humans.
Why it matters
Understanding Miro1's role could lead to new treatments for Type 2 diabetes.
Entities
Miro1· ProteinType 2 Diabetes· DiseaseDr. John P. Kirwan· PersonOU Health Harold Hamm Diabetes Center· OrganizationNature Communications· Publication
Source
Science Daily
